For more information on the event, speakers and agenda, download our printable PDF info sheet.
Medical Cannabis Seminar,
Oct 25, 2017 – Orlando, FL
This seminar will provide an update on the latest basic and clinical science on the use cannabinoids, including cannabidiol (CBD), the non-psychoactive component of cannabis. Recent evidence and studies suggest that cannabinoids may be a promising therapy. Twenty-nine states have recently approved the use of cannabis and cannabis-based products for the treatment of many conditions, including pain, insomnia, nausea, PTSD and seizures. CBD is largely available throughout the United States as a non-psychoactive agricultural product. Using a didactic format, we will review the pharmacology and neurobiology of cannabinoids. We will also review the pre-clinical and clinical evidence for efficacy.